Contra-indicated in patients with hypocalcemia.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Mimpara (Amgen); Sensipar (Amgen)
- INDICATIONS: Secondary hyperparathyroidism, parathyroid carcinoma
- CLASS: Calcimimetic
- HALF-LIFE: 30–40 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Antifungal agents, Atomoxetine, Carvedilol, Codeine, Conivaptan, CYP2D6 substrates, CYP3A4 inhibitors, Dasatinib, Desipramine, Fesoterodine, Flecainide, Food, Itraconazole, Ketoconazole, Metoprolol, Nebivolol, PEG-Interferon, Tacrolimus, Tamoxifen, Tetrabenazine, Thioridazine, Tramadol, Tricyclic antidepressants, Voriconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 11/16/2023
